OpenURL Connection Search

Select item for more details and to access through your institution.

Interference with nuclear factor kappa B and c-Jun NH<sub>2</sub>-terminal kinase signaling by TRAF6C small interfering RNA inhibits myeloma cell proliferation and enhances apoptosis.
Published in:
Oncogene, 2006, v. 25, n. 49, p. 6520, doi. 10.1038/sj.onc.1209653
By:
- Chen, H.;
- Li, M.;
- Campbell, R. A.;
- Burkhardt, K.;
- Zhu, D.;
- Li, S. G.;
- Lee, H. J.;
- Wang, C.;
- Zeng, Z.;
- Gordon, M. S.;
- Bonavida, B.;
- Berenson, J. R.
Publication type:
Article
Collection of peripheral blood progenitor cells (PBPC) based on a rising WBC and platelet count significantly increases the number of CD34<sup>+</sup> cells.
Published in:
Bone Marrow Transplantation, 1999, v. 24, n. 1, p. 25, doi. 10.1038/sj.bmt.1701817
By:
- Krieger, M S;
- Schiller, G;
- Berenson, J R;
- Stewart, K;
- Noga, S J;
- Ballester, O;
- Tarantolo, S;
- Stiff, P;
- Kuhn, D;
- Scherzo, E;
- Sing, A;
- Jacobs, C;
- White, J M;
- DiPersio, J
Publication type:
Article
Primary osteogenic sarcoma of the bladder. Case report and review of the literature.
Published in:
1986
By:
- Berenson, Ronald J.;
- Flynn, Steven;
- Freiha, Fuad S.;
- Kempson, Richard L.;
- Torti, Frank M.;
- Berenson, R J;
- Flynn, S;
- Freiha, F S;
- Kempson, R L;
- Torti, F M
Publication type:
journal article
Frequent demonstration of human herpesvirus 8 (HHV-8) in bone marrow biopsy samples from Turkish patients with multiple myeloma (MM).
Published in:
2001
By:
- Beksac, M;
- Ma, M;
- Akyerli, C;
- DerDanielian, M;
- Zhang, L;
- Liu, J;
- Arat, M;
- Konuk, N;
- Koc, H;
- Ozcelik, T;
- Vescio, R;
- Berenson, J R
Publication type:
journal article
Multiple myeloma: the cells of origin--a two-way street.
Published in:
1998
By:
- Berenson, J R;
- Vescio, R A;
- Said, J
Publication type:
journal article
Bendamustine: A Review of its Use in the Management of Chronic Lymphocytic Leukaemia, Rituximab-Refractory Indolent Non-Hodgkin's Lymphoma and Multiple Myeloma.
Published in:
2012
By:
- Hoy, Sheridan M.;
- Berenson, J. R.;
- Knauf, W.;
- Mantillo, M.;
- Rigacci, L.;
- Robak, T.;
- van der Jagt, R. H. C.
Publication type:
Journal Article
Bone disease in myeloma.
Published in:
2001
By:
- Berenson, James;
- Berenson, J R
Publication type:
journal article
Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases.
Published in:
2001
By:
- Berenson, James R.;
- Rosen, Lee S.;
- Howell, Anthony;
- Porter, Lester;
- Coleman, Robert E.;
- Morley, Walter;
- Dreicer, Robert;
- Kuross, Steven A.;
- Lipton, Allan;
- Seaman, John J.;
- Berenson, J R;
- Rosen, L S;
- Howell, A;
- Porter, L;
- Coleman, R E;
- Morley, W;
- Dreicer, R;
- Kuross, S A;
- Lipton, A;
- Seaman, J J
Publication type:
journal article
A Phase I, open label, dose ranging trial of intravenous bolus zoledronic acid, a novel bisphosphonate, in cancer patients with metastatic bone disease.
Published in:
2001
By:
- Berenson, James R.;
- Vescio, Robert;
- Henick, Kathryn;
- Nishikubo, Carol;
- Rettig, Matthew;
- Swift, Regina A.;
- Conde, Francisco;
- Von Teichert, Joseph M.;
- Berenson, J R;
- Vescio, R;
- Henick, K;
- Nishikubo, C;
- Rettig, M;
- Swift, R A;
- Conde, F;
- Von Teichert, J M
Publication type:
journal article
Serum BCMA levels predict outcomes in MGUS and smoldering myeloma patients.
Published in:
Blood Cancer Journal, 2021, v. 11, n. 6, p. 1, doi. 10.1038/s41408-021-00505-4
By:
- Visram, A.;
- Soof, C.;
- Rajkumar, S. V.;
- Kumar, S. K.;
- Bujarski, S.;
- Spektor, T. M.;
- Kyle, R. A.;
- Berenson, J. R.;
- Dispenzieri, A.
Publication type:
Article
Replacement of bortezomib with carfilzomib for multiple myeloma patients progressing from bortezomib combination therapy.
Published in:
Leukemia (08876924), 2014, v. 28, n. 7, p. 1529, doi. 10.1038/leu.2014.27
By:
- Berenson, J R;
- Hilger, J D;
- Yellin, O;
- Dichmann, R;
- Patel-Donnelly, D;
- Boccia, R V;
- Bessudo, A;
- Stampleman, L;
- Gravenor, D;
- Eshaghian, S;
- Nassir, Y;
- Swift, R A;
- Vescio, R A
Publication type:
Article
A phase 2 study of pegylated liposomal doxorubicin, bortezomib, dexamethasone and lenalidomide for patients with relapsed/refractory multiple myeloma.
Published in:
Leukemia (08876924), 2012, v. 26, n. 7, p. 1675, doi. 10.1038/leu.2012.51
By:
- Berenson, J R;
- Yellin, O;
- Kazamel, T;
- Hilger, J D;
- Chen, C-S;
- Cartmell, A;
- Woliver, T;
- Flam, M;
- Bravin, E;
- Nassir, Y;
- Vescio, R;
- Swift, R A
Publication type:
Article
Hematopoietic cell transplantation for primary plasma cell leukemia: results from the Center for International Blood and Marrow Transplant Research.
Published in:
Leukemia (08876924), 2012, v. 26, n. 5, p. 1091, doi. 10.1038/leu.2011.312
By:
- Mahindra, A;
- Kalaycio, M E;
- Vela-Ojeda, J;
- Vesole, D H;
- Zhang, M-J;
- Li, P;
- Berenson, J R;
- Bird, J M;
- Dispenzieri, A;
- Gajewski, J L;
- Gale, R P;
- Holmberg, L;
- Kumar, S;
- Kyle, R A;
- Lazarus, H M;
- Lonial, S;
- Mikhael, J;
- Milone, G A;
- Munker, R;
- Nath, R
Publication type:
Article
Efficacy of melphalan, arsenic trioxide, and ascorbic acid combination therapy (MAC) in relapsed and refractory multiple myeloma.
Published in:
2005
By:
- Borad, M J;
- Swift, R;
- Berenson, J R
Publication type:
Letter
Accessory cells do not contribute to G-CSF or IL-6 production nor to rapid haematological recovery following peripheral blood stem cell transplantation.
Published in:
British Journal of Haematology, 1995, v. 91, n. 3, p. 767, doi. 10.1111/j.1365-2141.1995.tb05384.x
By:
- Watts, M. J.;
- Jones, H. M.;
- Sullivan, A. M.;
- Langabeer, S. E.;
- Jamieson, E.;
- Fielding, A.;
- Williams, C.;
- Berenson, R. J.;
- Goldstone, A. H.;
- Linch, D. C.
Publication type:
Article

Found: 15